Herbal mix shows promise against COVID-19 in small trial
NCT ID NCT05043324
First seen Nov 01, 2025 · Last updated Jun 18, 2026 · Updated 38 times
Summary
This study tested a herbal supplement called AntiCov-220 in 82 adults with high-risk conditions like HIV or cancer. The goal was to see if it could prevent COVID-19 infection and reduce symptoms. The supplement contains a mix of herbs and vitamins thought to boost the immune system and fight the virus.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Saigon Biopharma Company Limited
Ho Chi Minh City, 700000, Vietnam
-
Saigon Biopharma LLC
Wilmington, Delaware, 19801-6601, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.